1Jacobsen EA, Ochkur SI, Lee NA, et al. Eosinophils and asthma[J]. Curr Allergy Asthma Rep,2007,7(1), 18-26.
2Nikolovski Z, Buzon V, Ribo M, et al. Thermal unfolding of eosinophil cationic protein/ribonuclease 3: a nonreversible process[J]. Protein Sci, 2006,15 (12) : 2816-2827.
3Kopriva F,Janost'akova A, Ordeltova M, et al. Study of the eosinophilic inflammation activity in bronchial asthma [J]. Casopic Lekaru Ceskych, 2007,146 (5) : 479-483.
4Dente FL, Carnevali S, Bartoli ML, et al. Profiles of proinflammatory cytokines in sputum ftom different groups of severe asthmatic patients[J]. Ann Allergy Asthma Immunol, 2006,97(3) :312-320.
5Badar A, Saeed W, Hussain MM, et al. Correlation of eosinophil cationic protein with severity of asthma[J]. J Ayub Med Coll Abbottabad, 2004,16 (3) : 66-71.
6Chu YT,Chiang W,Wang TN,et al. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma[J]. J Microbiol Immunol Infect, 2007,40(2): 162-167.
7Marcucci F, Passalacqua G, Canonica GW, et al. Lower airway inflammation before and after house dust mite nasal challenge; an age and allergen exposure-related phenomenon[J]. Respir Med, 2007,101 (7), 1600-1608.
8Tahamiler R, Yener M, Canakcioglu S. The use of serum and nasal eosinophilic cationic protein in the evaluation of the effectiveness of immunotherapy in patients with allergic rhinitis[J]. Kulak Burun Bogaz Ihtis Derg,2006,16(4) :155-159.
9Ciebiada M, Gorska-Ciebiada M, DuBuske LM, et al. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis [J]. Ann Allergy Asthma Immunol, 2006,97 (5) :664-671.
10Jenerowicz D, Czarnecka-Operacz M, Silny M. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients[J]. Acta Dermatovenerol Croat,2006, 14 (2):73-80.
